Cancer stem cell markers in head and neck squamous cell carcinoma

Stem Cells International

Volumn , Issue , 2013, Pages

  Major, Aidan G ^a   Pitty, Luke P ^a   Farah, Camile S ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER B5; ALDEHYDE DEHYDROGENASE; BREAST CANCER RESISTANCE PROTEIN; CHONDROITIN SULFATE PROTEOGLYCAN 4; CRIPTO 1 PROTEIN; HERMES ANTIGEN; LDEHYDE DEHYDROGENASE 1; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MUSASHI 1 PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN LGR5; PROTEOCHONDROITIN SULFATE; SCATTER FACTOR RECEPTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR TWIST; TUMOR MARKER; UNCLASSIFIED DRUG;

CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER STEM CELL; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL SUBPOPULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; METASTASIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REVIEW; TREATMENT FAILURE;

EID: 84875490598     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2013/319489     Document Type: Review

References (206)

1. Warnakulasuriya S., Global epidemiology of oral and oropharyngeal cancer. Oral Oncology 2009 45 4-5 309 316 2-s2.0-67349186933 10.1016/j.oraloncology. 2008.06.002
2. Scully C., Bagan J., Oral squamous cell carcinoma overview. Oral Oncology 2009 45 4-5 301 308 2-s2.0-67349154099 10.1016/j.oraloncology.2009.01.004
3. Zhang P., Zhang Y., Mao L., Zhang Z., Chen W., Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Letters 2009 277 2 227 234 2-s2.0-62949157910 10.1016/j.canlet.2008.12.015
4. Liebertz D. J., Lechner M. G., Masood R., Sinha U. K., Han J., Puri R. K., Correa A. J., Epstein A. L., Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1. Head and Neck Oncology 2010 2 1, article 5 2-s2.0-77953462791 10.1186/1758-3284-2-5
5. Sterz C. M., Kulle C., Dakic B., Makarova G., Böttcher M. C., Bette M., Werner J. A., Mandic R., A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. Oral Oncology 2010 46 2 116 122 2-s2.0-74649086713 10.1016/j.oraloncology.2009.11.011
6. McCullough M. J., Prasad G., Farah C. S., Oral mucosal malignancy and potentially malignant lesions: an update on the epidemiology, risk factors, diagnosis and management. Australian Dental Journal 2010 55 61 65 2-s2.0-79958101833
7. Prince M. E. P., Ailles L. E., Cancer stem cells in head and neck squamous cell cancer. Journal of Clinical Oncology 2008 26 17 2871 2875 2-s2.0-45549096553 10.1200/JCO.2007.15.1613
8. Chiou S. H., Yu C. C., Huang C. Y., Lin S. C., Liu C. J., Tsai T. H., Chou S. H., Chien C. S., Ku H. H., Lo J. F., Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clinical Cancer Research 2008 14 13 4085 4095 2-s2.0-48249105531 10.1158/1078-0432.CCR-07-4404
9. Kelly C., Paleri V., Downs C., Shah R., Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer. Otolaryngology 2007 136 1 108 111 2-s2.0-33845928602 10.1016/j.otohns.2006.06. 1278 (Pubitemid 46037900)
10. Rogers S. N., Ahad S. A., Murphy A. P., A structured review and theme analysis of papers published on 'quality of life' in head and neck cancer: 2000-2005. Oral Oncology 2007 43 9 843 868 2-s2.0-34548394662 10.1016/j.oraloncology.2007.02.006 (Pubitemid 47369258)
11. Oton-Leite A. F., Corrêa de Castro A. C., Morais M. O., Pinezi J. C. D., Leles C. R., Mendonça E. F., Effect of intraoral low-level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy. Head and Neck 2012 34 3 398 404 2-s2.0-79953734051 10.1002/hed.21737
12. Harper L. J., Costea D. E., Gammon L., Fazil B., Biddle A., Mackenzie I. C., Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance. BMC Cancer 2010 10, article 166 2-s2.0-77951571268 10.1186/1471-2407-10-166
13. Wong M. H., Monroe M. M., Anderson E. C., Clayburgh D. R., Cancer stem cells in head and neck squamous cell carcinoma. Journal of Oncology 2011 2011 8 2-s2.0-78650765103 10.1155/2011/762780 762780
14. Umezawa A., Gorham J. D., Dueling models in head and neck tumor formation. Laboratory Investigation 2010 90 11 1546 1548 2-s2.0-78049324419 10.1038/labinvest.2010.165
15. Ward R. J., Dirks P. B., Cancer stem cells: at the headwaters of tumor development. Annual Review of Pathology 2007 2 175 189 2-s2.0-33947433676 10.1146/annurev.pathol.2.010506.091847 (Pubitemid 46448063)
16. Prince M. E., Sivanandan R., Kaczorowski A., Wolf G. T., Kaplan M. J., Dalerba P., Weissman I. L., Clarke M. F., Ailles L. E., Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2007 104 3 973 978 2-s2.0-33846512398 10.1073/pnas.0610117104 (Pubitemid 46154721)
17. Chen Z., The cancer stem cell concept in progression of head and neck cancer. Journal of Oncology 2009 2009 8 2-s2.0-74549134050 10.1155/2009/894064 894064
18. Jordan C. T., Guzman M. L., Noble M., Cancer stem cells. New England Journal of Medicine 2006 355 12 1253 1261 2-s2.0-33748891391 10.1056/NEJMra061808 (Pubitemid 44427449)
19. Clarke M. F., Dick J. E., Dirks P. B., Eaves C. J., Jamieson C. H. M., Jones D. L., Visvader J., Weissman I. L., Wahl G. M., Cancer stem cells-perspectives on current status and future directions: AACR workshop on cancer stem cells. Cancer Research 2006 66 19 9339 9344 2-s2.0-33750313208 10.1158/0008-5472.CAN-06-3126 (Pubitemid 44623625)
20. Jordan C. T., Cancer stem cells: controversial or just misunderstood? Cell Stem Cell 2009 4 3 203 205 2-s2.0-60849097553 10.1016/j.stem.2009.02.003
21. Sayed S. I., Dwivedi R. C., Katna R., Garg A., Pathak K. A., Nutting C. M., Rhys-Evans P., Harrington K. J., Kazi R., Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral Oncology 2011 47 4 237 243 2-s2.0-79953066081 10.1016/j.oraloncology.2011.02.009
22. Bonnet D., Dick J. E., Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine 1997 3 7 730 737 2-s2.0-0030789242 10.1038/nm0797-730 (Pubitemid 27298715)
23. Al-Hajj M., Wicha M. S., Benito-Hernandez A., Morrison S. J., Clarke M. F., Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 3983 3988 2-s2.0-0037388204 10.1073/pnas.0530291100 (Pubitemid 36418143)
24. Charafe-Jauffret E., Monville F., Ginestier C., Dontu G., Birnbaum D., Wicha M. S., Cancer stem cells in breast: current opinion and future challenges. Pathobiology 2008 75 2 75 84 2-s2.0-44949169522 10.1159/000123845 (Pubitemid 351820725)
25. Singh S. K., Hawkins C., Clarke I. D., Squire J. A., Bayani J., Hide T., Henkelman R. M., Cusimano M. D., Dirks P. B., Identification of human brain tumour initiating cells. Nature 2004 432 7015 396 401 2-s2.0-9244241576 10.1038/nature03128 (Pubitemid 39551674)
26. Collins A. T., Berry P. A., Hyde C., Stower M. J., Maitland N. J., Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research 2005 65 23 10946 10951 2-s2.0-28244472369 10.1158/0008-5472.CAN-05-2018 (Pubitemid 41713363)
27. Xin L., Lawson D. A., Witte O. N., The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 2005 102 19 6942 6947 2-s2.0-18744377702 10.1073/pnas. 0502320102 (Pubitemid 40675421)
28. Eramo A., Lotti F., Sette G., Pilozzi E., Biffoni M., Di Virgilio A., Conticello C., Ruco L., Peschle C., De Maria R., Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death and Differentiation 2008 15 3 504 514 2-s2.0-39449088496 10.1038/sj.cdd.4402283 (Pubitemid 351267301)
29. Ricci-Vitiani L., Pagliuca A., Palio E., Zeuner A., De Maria R., Colon cancer stem cells. Gut 2008 57 4 538 548 2-s2.0-41149160205 10.1136/gut.2007. 127837 (Pubitemid 351442540)
30. Lee C. J., Li C., Simeone D. M., Human pancreatic cancer stem cells: implications for how we treat pancreatic cancer. Translational Oncology 2008 1 14 18
31. + cancer stem cells in human liver cancer. Cancer Cell 2008 13 2 153 166 2-s2.0-38549139140 10.1016/j.ccr.2008.01.013 (Pubitemid 351163165)
32. Fang D., Nguyen T. K., Leishear K., Finko R., Kulp A. N., Hotz S., van Belle P. A., Xu X., Elder D. E., Herlyn M., A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Research 2005 65 20 9328 9337 2-s2.0-27144557960 10.1158/0008-5472.CAN-05-1343 (Pubitemid 41508000)
33. Albers A. E., Chen C., Köberle B., Qian X., Klussmann J. P., Wollenberg B., Kaufmann A. M., Stem cells in squamous head and neck cancer. Critical Reviews in Oncology/Hematology 2012 81 3 224 240 10.1016/j.critrevonc. 2011.03.004
34. Visvader J. E., Lindeman G. J., Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Reviews Cancer 2008 8 10 755 768 2-s2.0-52549087785 10.1038/nrc2499
35. Al-Assar O., Muschel R. J., Mantoni T. S., McKenna W. G., Brunner T. B., Radiation response of cancer stem-like cells from established human cell lines after sorting for surface markers. International Journal of Radiation Oncology Biology Physics 2009 75 4 1216 1225 2-s2.0-70449721415 10.1016/j.ijrobp.2009.07. 001
36. Bao S., Wu Q., McLendon R. E., Hao Y., Shi Q., Hjelmeland A. B., Dewhirst M. W., Bigner D. D., Rich J. N., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006 444 7120 756 760 2-s2.0-33845317573 10.1038/nature05236 (Pubitemid 44949604)
37. + cells display stem-like features and are spared by cisplatin treatment. Proceedings of the National Academy of Sciences of the United States of America 2009 106 38 16281 16286 2-s2.0-70349479538 10.1073/pnas.0905653106
38. Chang C. J., Hsu C. C., Yung M. C., Chen K. Y., Tzao C., Wu W. F., Chou H. Y., Lee Y. Y., Lu K. H., Chiou S. H., Ma H. I., Enhanced radiosensitivity and radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1 expression. Biochemical and Biophysical Research Communications 2009 380 2 236 242 2-s2.0-60349085855 10.1016/j.bbrc.2009.01.040
39. Diehn M., Clarke M. F., Cancer stem cells and radiotherapy: new insights into tumor radioresistance. Journal of the National Cancer Institute 2006 98 24 1755 1757 2-s2.0-33845874094 10.1093/jnci/djj505 (Pubitemid 46017927)
40. Hong S. P., Wen J., Bang S., Park S., Si Y. S., CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. International Journal of Cancer 2009 125 10 2323 2331 2-s2.0-70349873330 10.1002/ijc.24573
41. + glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines. Clinical Cancer Research 2009 15 16 5145 5153 2-s2.0-69349095324 10.1158/1078-0432.CCR- 09-0263
42. Chiou S. H., Yu C. C., Lo W. L., Chen Y. W., Huang P. I., Hsu H. S., Tseng L. M., Hung S. C., Kao S. Y., Chang C. J., Bmi-1 regulates snail expression and promotes metastasis ability in head and neck squamous cancer-derived ALDH1 positive cells. Journal of Oncology 2011 2011 16 2-s2.0-78349295300 10.1155/2011/609259 609259
43. + cells in oral cancer cell lines. Journal of Dental Research 2011 90 5 638 645 2-s2.0-79955838727 10.1177/0022034510393511
44. Baumann M., Krause M., Hill R., Exploring the role of cancer stem cells in radioresistance. Nature Reviews Cancer 2008 8 7 545 554 2-s2.0-45849089879 10.1038/nrc2419 (Pubitemid 351881850)
45. Frank N. Y., Schatton T., Frank M. H., The therapeutic promise of the cancer stem cell concept. Journal of Clinical Investigation 2010 120 1 41 50 2-s2.0-74949090309 10.1172/JCI41004
46. Dalerba P., Cho R. W., Clarke M. F., Cancer stem cells: models and concepts. Annual Review of Medicine 2007 58 267 284 2-s2.0-34047096557 10.1146/annurev.med.58.062105.204854 (Pubitemid 46706514)
47. Rasheed Z. A., Kowalski J., Smith B. D., Matsui W., Concise review: emerging concepts in clinical targeting of cancer stem cells. Stem Cells 2011 29 6 883 887 2-s2.0-79957622341 10.1002/stem.648
48. Baum B., Settleman J., Quinlan M. P., Transitions between epithelial and mesenchymal states in development and disease. Seminars in Cell and Developmental Biology 2008 19 3 294 308 2-s2.0-41549162752 10.1016/j.semcdb. 2008.02.001
49. Brabletz T., Jung A., Spaderna S., Hlubek F., Kirchner T., Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nature Reviews Cancer 2005 5 9 744 749 2-s2.0-25444495269 10.1038/nrc1694 (Pubitemid 41486367)
50. Chen C., Wei Y., Hummel M., Hoffmann T. K., Gross M., Kaufmann A. M., Albers A. E., Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS ONE 2011 6 1 2-s2.0-79551522569 10.1371/journal.pone.0016466 e16466
51. Davis S. J., Divi V., Owen J. H., Bradford C. R., Carey T. E., Papagerakis S., Prince M. E. P., Metastatic potential of cancer stem cells in head and neck squamous cell carcinoma. Archives of Otolaryngology 2010 136 12 1260 1266 2-s2.0-78650837988 10.1001/archoto.2010.219
52. Orian-Rousseau V., CD44, a therapeutic target for metastasising tumours. European Journal of Cancer 2010 46 7 1271 1277 2-s2.0-77950561915 10.1016/j.ejca.2010.02.024
53. + cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010 6 6 603 615 2-s2.0-77956641496 10.1016/j.stem.2010.04.001
54. + cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis. International Journal of Cancer 2011 129 10 2337 2348 10.1002/ijc.25927
55. Radisky D. C., LaBarge M. A., Epithelial-mesenchymal transition and the stem cell phenotype. Cell Stem Cell 2008 2 6 511 512 2-s2.0-44349139461 10.1016/j.stem.2008.05.007 (Pubitemid 351729219)
56. Mishra A., Verma M., Cancer biomarkers: are we ready for the prime time? Cancers 2010 2 1 190 208 2-s2.0-79951757281 10.3390/cancers2010190
57. + cancer stem-like cells in squamous cell carcinoma of the head and neck. Head and Neck 2011 33 2 208 215 2-s2.0-78751553162 10.1002/hed.21420
58. Yu Q., Toole B. P., Stamenkovic I., Induction of apoptosis of metastatic mammary carcinoma cells invivo by disruption of tumor cell surface CD44 function. Journal of Experimental Medicine 1997 186 12 1985 1996 2-s2.0-0031453690 10.1084/jem.186.12.1985 (Pubitemid 28013682)
59. Yu Q., Stamenkovic I., Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes and Development 1999 13 1 35 48 2-s2.0-0032926177 (Pubitemid 29045114)
60. Kim H. R., Wheeler M. A., Wilson C. M., Iida J., Eng D., Simpson M. A., McCarthy J. B., Bullard K. M., Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Research 2004 64 13 4569 4576 2-s2.0-3042738008 10.1158/0008-5472.CAN-04-0202 (Pubitemid 38856930)
61. Golshani R., Lopez L., Estrella V., Kramer M., Iida N., Lokeshwar V. B., Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Cancer Research 2008 68 2 483 491 2-s2.0-39049168749 10.1158/0008-5472.CAN-07-2140 (Pubitemid 351380075)
62. Kajita M., Itoh Y., Chiba T., Mori H., Okada A., Kinoh H., Seiki M., Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. Journal of Cell Biology 2001 153 5 893 904 2-s2.0-0035947766 10.1083/jcb.153.5.893 (Pubitemid 34289231)
63. Isacke C. M., Yarwood H., The hyaluronan receptor, CD44. International Journal of Biochemistry and Cell Biology 2002 34 7 718 721 2-s2.0-0036223281 10.1016/S1357-2725(01)00166-2 (Pubitemid 34304161)
64. Dalerba P., Dylla S. J., Park I. K., Liu R., Wang X., Cho R. W., Hoey T., Gurney A., Huang E. H., Simeone D. M., Shelton A. A., Parmiani G., Castelli C., Clarke M. F., Phenotypic characterization of human colorectal cancer stem cells. Proceedings of the National Academy of Sciences of the United States of America 2007 104 24 10158 10163 2-s2.0-34547193404 10.1073/pnas.0703478104 (Pubitemid 47175279)
65. Li C., Heidt D. G., Dalerba P., Burant C. F., Zhang L., Adsay V., Wicha M., Clarke M. F., Simeone D. M., Identification of pancreatic cancer stem cells. Cancer Research 2007 67 3 1030 1037 2-s2.0-33847052127 10.1158/0008-5472.CAN- 06-2030
66. O'Brien C. A., Pollett A., Gallinger S., Dick J. E., A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007 445 7123 106 110 2-s2.0-33846100356 10.1038/nature05372 (Pubitemid 46067310)
67. Singh S. K., Clarke I. D., Terasaki M., Bonn V. E., Hawkins C., Squire J., Dirks P. B., Identification of a cancer stem cell in human brain tumors. Cancer Research 2003 63 18 5821 5828 2-s2.0-0141842674 (Pubitemid 37187480)
68. Okamoto A., Chikamatsu K., Sakakura K., Hatsushika K., Takahashi G., Masuyama K., Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck. Oral Oncology 2009 45 7 633 639 2-s2.0-67449095320 10.1016/j.oraloncology.2008.10.003
69. Harper L. J., Piper K., Common J., Fortune F., Mackenzie I. C., Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. Journal of Oral Pathology and Medicine 2007 36 10 594 603 2-s2.0-35349017905 10.1111/j.1600-0714.2007.00617.x (Pubitemid 47609813)
70. Gammon L., Biddle A., Fazil B., Harper L., Mackenzie I. C., Stem cell characteristics of cell sub-populations in cell lines derived from head and neck cancers of Fanconi anemia patients. Journal of Oral Pathology and Medicine 2011 40 2 143 152 2-s2.0-79251568305 10.1111/j.1600-0714.2010.00972.x
71. Chen Y. C., Chen Y. W., Hsu H. S., Tseng L. M., Huang P. I., Lu K. H., Chen D. T., Tai L. K., Yung M. C., Chang S. C., Ku H. H., Chiou S. H., Lo W. L., Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochemical and Biophysical Research Communications 2009 385 3 307 313 2-s2.0-67349209852 10.1016/j.bbrc.2009.05.048
72. Joshua B., Kaplan M. J., Doweck I., Pai R., Weissman I. L., Ailles L. E., Frequency of cells expressing CD44, a Head and Neck cancer stem cell marker: correlation with tumor aggressiveness. Head and Neck 2012 34 1 42 49 10.1002/hed.21699
73. Oliveira L. R., Oliveira-Costa J. P., Araujo I. M., Soave D. F., Zanetti J. S., Soares F. A., Zucoloto S., Ribeiro-Silva A., Cancer stem cell immunophenotypes in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine 2011 40 2 135 142 2-s2.0-79251567072 10.1111/j.1600-0714.2010.00967.x
74. + cells in human nasopharyngeal carcinoma cell line. Archives of Medical Research 2011 42 1 15 21 2-s2.0-79952081749 10.1016/j.arcmed.2011.01.007
75. Wang S. J., Wong G., De Heer A. M., Xia W., Bourguignon L. Y. W., CD44 Variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope 2009 119 8 1518 1530 2-s2.0-68849088549 10.1002/lary.20506
76. Kokko L. L., Hurme S., Maula S. M., Alanen K., Grénman R., Kinnunen I., Ventelä S., Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma. Oral Oncology 2011 47 6 510 516 2-s2.0-79958054545 10.1016/j.oraloncology.2011.03.026
77. Lin J. T., Chang T. H., Chang C. S., Wang W. H., Su B. W., Lee K. D., Chang P. J., Prognostic value of pretreatment CD44 mRNA in peripheral blood of patients with locally advanced head and neck cancer. Oral Oncology 2010 46 5 e29 e33 2-s2.0-77950938830 10.1016/j.oraloncology.2010.02.011
78. Mack B., Gires O., CD44s and CD44v6 expression in head and neck epithelia. PLoS ONE 2008 3 10 2-s2.0-54449085703 10.1371/journal.pone.0003360 e3360
79. Lim Y. C., Oh S. Y., Cha Y. Y., Kim S. H., Jin X., Kim H., Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncology 2011 47 2 83 91 2-s2.0-79551686424 10.1016/j.oraloncology.2010.11.011
80. Clay M. R., Tabor M., Owen J. H., Carey T. E., Bradford C. R., Wolf G. T., Wicha M. S., Prince M. E., Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head and Neck 2010 32 9 1195 1201 2-s2.0-77954901231 10.1002/hed.21315
81. Ginestier C., Hur M. H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C. G., Liu S., Schott A., Hayes D., Birnbaum D., Wicha M. S., Dontu G., ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007 1 5 555 567 2-s2.0-35848955428 10.1016/j.stem.2007.08.014 (Pubitemid 350056407)
82. Huang E. H., Hynes M. J., Zhang T., Ginestier C., Dontu G., Appelman H., Fields J. Z., Wicha M. S., Boman B. M., Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Research 2009 69 8 3382 3389 2-s2.0-65949112714 10.1158/0008-5472.CAN-08-4418
83. Jiang F., Qiu Q., Khanna A., Todd N. W., Deepak J., Lingxiao X., Huijun W., Zhenqiu L., Yun S., Stass S. A., Katz R. L., Aldehyde dehydrogenase 1 is a tumor stem cell-Associated marker in lung cancer. Molecular Cancer Research 2009 7 3 330 338 2-s2.0-62549152644 10.1158/1541-7786.MCR-08-0393
84. Ma S., Kwok W. C., Lee T. K. W., Kwan H. T., Wo J. Y. H., Zheng B. J., Guan X. Y., Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Molecular Cancer Research 2008 6 7 1146 1153 2-s2.0-51649119918 10.1158/1541-7786.MCR-08-0035
85. Chen Y. C., Chang C. J., Hsu H. S., Chen Y. W., Tai L. K., Tseng L. M., Chiou G. Y., Chang S. C., Kao S. Y., Chiou S. H., Lo W. L., Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncology 2010 46 3 158 165 2-s2.0-76749158386 10.1016/j.oraloncology.2009.11.007
86. Koukourakis M. I., Giatromanolaki A., Tsakmaki V., Sivridis E., Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer. British Journal of Cancer 2012 106 5 846 853 10.1038/bjc.2012.33
87. Wu Y., Wu P. Y., CD133 as a marker for cancer stem cells: progresses and concerns. Stem Cells and Development 2009 18 8 1127 1134 2-s2.0-70349100257 10.1089/scd.2008.0338
88. + cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy. Cancer Letters 2010 289 2 151 160 2-s2.0-76849098162 10.1016/j.canlet.2009.08.010
89. Wei X. D., Zhou L., Cheng L., Tian J., Jiang J. J., MacCallum J., In vivo investigation of CD133 as a putative marker of cancer stem cells in hep-2 cell line. Head and Neck 2009 31 1 94 101 2-s2.0-58149508462 10.1002/hed.20935
90. Sun Y., Han J., Lu Y., Yang X., Fan M., Biological characteristics of a cell subpopulation in tongue squamous cell carcinoma. Oral Diseases 2012 18 2 169 177 10.1111/j.1601-0825.2011.01860.x
91. - metastatic colon cancer cells initiate tumors. Journal of Clinical Investigation 2008 118 6 2111 2120 2-s2.0-45749102020 10.1172/JCI34401 (Pubitemid 351872330)
92. Wang J., Sakariassen P. Ø., Tsinkalovsky O., Immervoll H., Bøe S. O., Svendsen A., Prestegarden L., Røsland G., Thorsen F., Stuhr L., Molven A., Bjerkvig R., Enger P. Ø., CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. International Journal of Cancer 2008 122 4 761 768 2-s2.0-38349075007 10.1002/ijc.23130
93. Ogden A. T., Waziri A. E., Lochhead R. A., Fusco D., Lopez K., Ellis J. A., Kang J., Assanah M., McKhann G. M., Sisti M. B., McCormick P. C., Canoll P., Bruce J. N., Identification of A2B5+CD133-tumor-initiating cells in adult human gliomas. Neurosurgery 2008 62 2 505 514 2-s2.0-41749118669 10.1227/01.neu. 0000316019.28421.95
94. LaBarge M. A., Bissell M. J., Is CD133 a marker of metastatic colon cancer stem cells? Journal of Clinical Investigation 2008 118 6 2021 2024 2-s2.0-45749125992 10.1172/JCI36046 (Pubitemid 351872322)
95. Lim Y. C., Han J. H., Kang H. J., Choi E. C., Kim C.-H., Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma. Oral Oncology 2012 48 11 1114 1119 10.1016/j.oraloncology.2012.05.013
96. Zhao D., Wang S.-H., Feng Y., Hua C.-G., Zhao J., Tang X.-F., Intratumoral c-Met expression is associated with vascular endothelial growth factor C expression, lymphangiogenesis, and lymph node metastasis in oral squamous cell carcinoma: implications for use as a prognostic marker. Human Pathology 2011 42 10 1514 1523 10.1016/j.humpath.2010.03.012
97. Dou J., Gu N., Emerging strategies for the identification and targeting of cancer stem cells. Tumor Biology 2010 31 4 243 253 2-s2.0-77954646313 10.1007/s13277-010-0023-y
98. Liu W., Feng J.-Q., Shen X.-M., Wang H.-Y., Liu Y., Zhou Z.-T., Two stem cell markers, ATP-binding cassette, G2 subfamily (ABCG2) and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study. Cancer 2012 118 6 1693 1700 10.1002/cncr.26483
99. Grimm M., Krimmel M., Polligkeit J., Munz A., Kluba S., Keutel C., Hoffmann J., Reinert S., Hoefert S., ABCB5 expression and cancer stem cell hypothesis in oral squamous cell carcinoma. European Journal of Cancer 2012 48 17 3186 3197 10.1016/j.ejca.2012.05.027
100. Chan Y. S., Yang L., Ng H. H., Transcriptional regulatory networks in embryonic stem cells. Progress in Drug Research 2011 67 239 252 2-s2.0-79952111741
101. Wang X., Wang Y., Yu L., Sakakura K., Visus C., Schwab J. H., Ferrone C. R., Koya Y., Campoli M. R., Mccarthy J. B., Deleo A. B., Ferrone S., CSPG4 in cancer: multiple roles. Current Molecular Medicine 2010 10 4 419 429 10.2174/156652410791316977
102. Ohtsuka S., Dalton S., Molecular and biological properties of pluripotent embryonic stem cells. Gene Therapy 2008 15 2 74 81 2-s2.0-37749016977 10.1038/sj.gt.3303065
103. Okamoto K., Okazawa H., Okuda A., Sakai M., Muramatsu M., Hamada H., A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 1990 60 3 461 472 2-s2.0-0025060177 10.1016/0092-8674(90) 90597-8 (Pubitemid 20060875)
104. Rosner M. H., Vigano M. A., Ozato K., Timmons P. M., Poirier F., Rigby P. W. J., Staudt L. M., A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 1990 345 6277 686 692 2-s2.0-0025352402 10.1038/345686a0 (Pubitemid 20186546)
105. Chambers I., Colby D., Robertson M., Nichols J., Lee S., Tweedie S., Smith A., Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003 113 5 643 655 2-s2.0-0038143611 10.1016/S0092-8674(03)00392-1 (Pubitemid 36694189)
106. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S., The homeoprotein nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003 113 5 631 642 2-s2.0-0037806031 10.1016/S0092-8674(03)00393-3 (Pubitemid 36694188)
107. Avilion A. A., Nicolis S. K., Pevny L. H., Perez L., Vivian N., Lovell-Badge R., Multipotent cell lineages in early mouse development depend on SOX2 function. Genes and Development 2003 17 1 126 140 2-s2.0-0037227099 10.1101/gad.224503 (Pubitemid 36062514)
108. Okita K., Ichisaka T., Yamanaka S., Generation of germline-competent induced pluripotent stem cells. Nature 2007 448 7151 313 317 2-s2.0-34249880066 10.1038/nature05934 (Pubitemid 47080336)
109. Park I. H., Zhao R., West J. A., Yabuuchi A., Huo H., Ince T. A., Lerou P. H., Lensch M. W., Daley G. Q., Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008 451 7175 141 146 2-s2.0-38049187707 10.1038/nature06534
110. Yu J., Vodyanik M. A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J. L., Tian S., Nie J., Jonsdottir G. A., Ruotti V., Stewart R., Slukvin I. I., Thomson J. A., Induced pluripotent stem cell lines derived from human somatic cells. Science 2007 318 5858 1917 1920 2-s2.0-36749043230 10.1126/science. 1151526
111. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Schöler H., Smith A., Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998 95 3 379 391 2-s2.0-0032582513 10.1016/S0092-8674(00)81769-9 (Pubitemid 28507326)
112. Gidekel S., Pizov G., Bergman Y., Pikarsky E., Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 2003 4 5 361 370 2-s2.0-0344063368 10.1016/S1535-6108(03)00270-8 (Pubitemid 37491097)
113. Tai M. H., Chang C. C., Olson L. K., Trosko J. E., Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005 26 2 495 502 2-s2.0-13844280894 10.1093/carcin/bgh321 (Pubitemid 40246573)
114. Abelev G. I., Lazarevich N. L., Control of differentiation in progression of epithelial tumors. Advances in Cancer Research 2006 95 61 113 2-s2.0-33746002609 10.1016/S0065-230X(06)95003-9 (Pubitemid 44066524)
115. Siu A., Lee C., Dang D., Lee C., Ramos D. M., Stem cell markers as predictors of oral cancer invasion. Anticancer Research 2012 32 4 1163 1166
116. Tsai L.-L., Yu C.-C., Chang Y.-C., Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine 2011 40 8 621 628 10.1111/j.1600-0714. 2011.01015.x
117. Ge N., Lin H. X., Xiao X. S., Guo L., Xu H. M., Wang X., Jin T., Cai X. Y., Liang Y., Hu W. H., Kang T., Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma. Journal of Translational Medicine 2010 8, article 94 2-s2.0-77957725410 10.1186/1479-5876-8-94
118. Bass A. J., Watanabe H., Mermel C. H., Yu S., Perner S., Verhaak R. G., Kim S. Y., Wardwell L., Tamayo P., Gat-Viks I., Ramos A. H., Woo M. S., Weir B. A., Getz G., Beroukhim R., O'Kelly M., Dutt A., Rozenblatt-Rosen O., Dziunycz P., Komisarof J., Chirieac L. R., Lafargue C. J., Scheble V., Wilbertz T., Ma C., Rao S., Nakagawa H., Stairs D. B., Lin L., Giordano T. J., Wagner P., Minna J. D., Gazdar A. F., Zhu C. Q., Brose M. S., Cecconello I., Marie S. K., Dahl O., Shivdasani R. A., Tsao M. S., Rubin M. A., Wong K. K., Regev A., Hahn W. C., Beer D. G., Rustgi A. K., Meyerson M., SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nature Genetics 2009 41 11 1238 1242 2-s2.0-70350641014 10.1038/ng.465
119. NTR in malignancy. Journal of Oral Pathology and Medicine 2013 42 1 37 46 10.1111/j.1600-0714.2012.01170.x
120. Thiery J. P., Epithelial-mesenchymal transitions in development and pathologies. Current Opinion in Cell Biology 2003 15 6 740 746 2-s2.0-0344845003 10.1016/j.ceb.2003.10.006 (Pubitemid 37487967)
121. Thiery J. P., Sleeman J. P., Complex networks orchestrate epithelial-mesenchymal transitions. Nature Reviews Molecular Cell Biology 2006 7 2 131 142 2-s2.0-33244463813 10.1038/nrm1835 (Pubitemid 43278296)
122. Tsuji T., Ibaragi S., Shima K., Hu M. G., Katsurano M., Sasaki A., Hu G. F., Epithelial-mesenchymal transition induced by growth suppressor p12 CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth. Cancer Research 2008 68 24 10377 10386 2-s2.0-57749092869 10.1158/0008-5472.CAN-08-1444
123. Kupferman M. E., Jiffar T., El-Naggar A., Yilmaz T., Zhou G., Xie T., Feng L., Wang J., Holsinger F. C., Yu D., Myers J. N., TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 2010 29 14 2047 2059 2-s2.0-77950867351 10.1038/onc.2009.486
124. Blanco M. J., Moreno-Bueno G., Sarrio D., Locascio A., Cano A., Palacios J., Nieto M. A., Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002 21 20 3241 3246 2-s2.0-0037046505 10.1038/sj/onc/1205416 (Pubitemid 34548095)
125. Ginos M. A., Page G. P., Michalowicz B. S., Patel K. J., Volker S. E., Pambuccian S. E., Ondrey F. G., Adams G. L., Gaffney P. M., Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Research 2004 64 1 55 63 2-s2.0-1642494850 10.1158/0008-5472.CAN-03-2144 (Pubitemid 38114082)
126. Yang J., Mani S. A., Weinberg R. A., Exploring a new twist on tumor metastasis. Cancer Research 2006 66 9 4549 4552 2-s2.0-33646408400 10.1158/0008-5472.CAN-05-3850
127. Yang M. H., Wu M. Z., Chiou S. H., Chen P. M., Chang S. Y., Liu C. J., Teng S. C., Wu K. J., Direct regulation of TWIST by HIF-1 α promotes metastasis. Nature Cell Biology 2008 10 3 295 305 2-s2.0-40249113328 10.1038/ncb1691 (Pubitemid 351331016)
128. Meulemans D., Bronner-Fraser M., Gene-regulatory interactions in neural crest evolution and development. Developmental Cell 2004 7 3 291 299 2-s2.0-4544378019 10.1016/j.devcel.2004.08.007 (Pubitemid 39232966)
129. Reya T., Clevers H., Wnt signalling in stem cells and cancer. Nature 2005 434 7035 843 850 2-s2.0-17244376814 10.1038/nature03319 (Pubitemid 40558990)
130. Song J., Chang I., Chen Z., Kang M., Wang C. Y., Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling. PLoS ONE 2010 5 7 2-s2.0-77955372945 10.1371/journal.pone.0011456 e11456
131. Chu P.-Y., Hu F.-W., Yu C. C., Tsai L.-L., Wu B.-C., Chen Y.-W., Huang P.-I., Lo W.-L., Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer. Oral Oncology 2013 49 1 34 41 10.1016/j.oraloncology.2012.07.012
132. Häyry V., Mäkinen L. K., Atula T., Sariola H., Mäkitie A., Leivo I., Keski-Säntti H., Lundin J., Haglund C., Hagström J., Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue. British Journal of Cancer 2010 102 5 892 897 2-s2.0-77649274663 10.1038/sj.bjc.6605544
133. Kang M. K., Kim R. H., Kim S. J., Yip F. K., Shin K. H., Dimri G. P., Christensen R., Han T., Park N. H., Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. British Journal of Cancer 2007 96 1 126 133 2-s2.0-33846211524 10.1038/sj.bjc.6603529 (Pubitemid 46094649)
134. Chen C. Y., Chiou S. H., Huang C. Y., Jan C. I., Lin S. C., Tsai M. L., Lo J. F., Distinct population of highly malignant cells in a head and neck squamous cell carcinoma cell line established by xenograft model. Journal of Biomedical Science 2009 16 1, article 100 2-s2.0-72449192666 10.1186/1423-0127-16-100
135. + head and neck squamous cell carcinoma cells. Head and Neck 2011 34 3 336 343 2-s2.0-79953754133 10.1002/hed.21732
136. Ganguli-Indra G., Wasylyk C., Liang X., Millon R., Leid M., Wasylyk B., Abecassis J., Indra A., CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status. PLoS ONE 2009 4 4 2-s2.0-65449184521 10.1371/journal.pone.0005367 e5367
137. Lo W. L., Yu C. C., Chiou G. Y., Chen Y. W., Huang P. I., Chien C. S., Tseng L. M., Chu P. Y., Lu K. H., Chang K. W., Kao S. Y., Chiou S. H., MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. Journal of Pathology 2011 223 4 482 495 2-s2.0-79551708071 10.1002/path.2826
138. Chen H., Zhou L., Wan G., Dou T., Tian J., BMI1 promotes the progression of laryngeal squamous cell carcinoma. Oral Oncology 2011 47 6 472 481 2-s2.0-79958029138 10.1016/j.oraloncology.2011.03.016
139. Attner P., Du J., Näsman A., Hammarstedt L., Ramqvist T., Lindholm J., Marklund L., Dalianis T., Munck-Wikland E., The role of human papillomavirus in the increased incidence of base of tongue cancer. International Journal of Cancer 2010 126 12 2879 2884 2-s2.0-77951885317 10.1002/ijc.24994
140. Liang X. H., Lewis J., Foote R., Smith D., Kademani D., Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic Experience. Journal of Oral and Maxillofacial Surgery 2008 66 9 1875 1880 2-s2.0-49549122217 10.1016/j.joms.2008.04.009
141. Zeki S. S., Graham T. A., Wright N. A., Stem cells and their implications for colorectal cancer. Nature Reviews Gastroenterology and Hepatology 2011 8 2 90 100 10.1038/nrgastro.2010.211
142. Barker N., van Es J. H., Kuipers J., Kujala P., van Den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P. J., Clevers H., Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007 449 7165 1003 1007 2-s2.0-35548974423 10.1038/nature06196 (Pubitemid 350014593)
143. Von Rahden B. H. A., Kircher S., Lazariotou M., Reiber C., Stuermer L., Otto C., Germer C. T., Grimm M., LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's Esophagus? Journal of Experimental and Clinical Cancer Research 2011 30 1, article 23 2-s2.0-79951850400 10.1186/1756-9966-30-23
144. McClanahan T., Koseoglu S., Smith K., Grein J., Gustafson E., Black S., Kirschmeier P., Samatar A. A., Identification of overexpression of orphan G Protein-Coupled Receptor GPR49 in human colon and ovarian primary tumors. Cancer Biology and Therapy 2006 5 4 419 426 2-s2.0-33646419556
145. Yamamoto Y., Sakamoto M., Fujii G., Tsuiji H., Kanetaka K., Asaka M., Hirohashi S., Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with β -catenin mutations. Hepatology 2003 37 3 528 533 2-s2.0-0037369658 10.1053/jhep.2003.50029 (Pubitemid 36258773)
146. +ve cancer stem cells in the colon and rectum. Annals of Surgical Oncology 2011 18 4 1166 1174 2-s2.0-79955800644 10.1245/s10434-010- 1373-9
147. Barker N., Clevers H., Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology 2010 138 5 1681 1696 2-s2.0-77951833781 10.1053/j.gastro.2010.03.002
148. Haegebarth A., Clevers H., Wnt signaling, Lgr5, and stem cells in the intestine and skin. American Journal of Pathology 2009 174 3 715 721 2-s2.0-62549118631 10.2353/ajpath.2009.080758
149. Tanese K., Fukuma M., Yamada T., Mori T., Yoshikawa T., Watanabe W., Ishiko A., Amagai M., Nishikawa T., Sakamoto M., G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation. American Journal of Pathology 2008 173 3 835 843 2-s2.0-51349161304 10.2353/ajpath.2008.071091
150. van de Wetering M., Sancho E., Verweij C., De Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A. P., Tjon-Pon-Fong M., Moerer P., van den Born M., Soete G., Pals S., Eilers M., Medema R., Clevers H., The β -catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002 111 2 241 250 2-s2.0-18644373146 10.1016/S0092-8674(02)01014-0 (Pubitemid 35292444)
151. Morita H., Mazerbourg S., Bouley D. M., Luo C. W., Kawamura K., Kuwabara Y., Baribault H., Tian H., Hsueh A. J. W., Neonatal lethality of LGR5 null mice is associated with ankyloglossia and gastrointestinal distension. Molecular and Cellular Biology 2004 24 22 9736 9743 2-s2.0-7644230387 10.1128/MCB.24.22.9736- 9743.2004 (Pubitemid 39458802)
152. Suomalainen M., Thesleff I., Patterns of Wnt pathway activity in the mouse incisor indicate absence of Wnt/ β -catenin signaling in the epithelial stem cells. Developmental Dynamics 2010 239 1 364 372 2-s2.0-73949147370 10.1002/dvdy.22106
153. Kawahara H., Imai T., Imataka H., Tsujimoto M., Matsumoto K., Okano H., Neural RNA-binding protein Musashi1 inhibits translation initiation by competing with eIF4G for PABP. Journal of Cell Biology 2008 181 4 639 653 2-s2.0-44149086912 10.1083/jcb.200708004 (Pubitemid 351717511)
154. Wang X. Y., Yin Y., Yuan H., Sakamaki T., Okano H., Glazer R. I., Musashi1 modulates mammary progenitor cell expansion through proliferin-mediated activation of the wnt and notch pathways. Molecular and Cellular Biology 2008 28 11 3589 3599 2-s2.0-44349125782 10.1128/MCB.00040-08 (Pubitemid 351732897)
155. Sureban S. M., May R., George R. J., Dieckgraefe B. K., McLeod H. L., Ramalingam S., Bishnupuri K. S., Natarajan G., Anant S., Houchen C. W., Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo. Gastroenterology 2008 134 5 1448 1458 2-s2.0-42949142611 10.1053/j.gastro.2008. 02.057 (Pubitemid 351615372)
156. Bianco C., Strizzi L., Normanno N., Khan N., Salomon D. S., Cripto-1: an oncofetal gene with many faces. Current Topics in Developmental Biology 2005 67 85 133 2-s2.0-33646154655 10.1016/S0070-2153(05)67003-2 (Pubitemid 43631284)
157. Adewumi O., Aflatoonian B., Ahrlund-Richter L., Amit M., Andrews P. W., Beighton G., Benvenisty N., Berry L. S., Bevan S., Blum B., Brooking J., Chen K. G., Choo A. B. H., Churchill G. A., Corbel M., Damjanov I., Draper J. S., Dvorak P., Emanuelsson K., Fleck R. A., Ford A., Gertow K., Gertsenstein M., Gokhale P. J., Hamilton R. S., Hampl A., Healy L. E., Hovatta O., Hyllner J., Imreh M. P., Itskovitz-Eldor J., Jackson J., Johnson J. L., Jones M., Kee K., King B. L., Knowles B. B., Lako M., Lebrin F., Mallon B. S., Manning D., Mayshar Y., McKay R. D. G., Michalska A. E., Mikkola M., Mileikovsky M., Minger S. L., Moore H. D., Mummery C. L., Nagy A., Nakatsuji N., O'Brien C. M., Oh S. K. W., Olsson C., Otonkoski T., Park K.-Y., Passier R., Patel H., Patel M., Pedersen R., Pera M. F., Piekarczyk M. S., Pera R. A. R., Reubinoff B. E., Robins A. J., Rossant J., Rugg-Gunn P., Schulz T. C., Semb H., Sherrer E. S., Siemen H., Stacey G. N., Stojkovic M., Suemori H., Szatkiewicz J., Turetsky T., Tuuri T., van Den Brink S., Vintersten K., Ward D., Weaver T. A., Young L. A., Zhang W., Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nature Biotechnology 2007 25 7 803 816 10.1038/nbt1318 (Pubitemid 47052190)
158. Strizzi L., Bianco C., Normanno N., Salomon D., Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene 2005 24 37 5731 5741 2-s2.0-24644493315 10.1038/sj.onc.1208918 (Pubitemid 43086133)
159. Montesano R., Sarközi R., Schramek H., Bone morphogenetic protein-4 strongly potentiates growth factor-induced proliferation of mammary epithelial cells. Biochemical and Biophysical Research Communications 2008 374 1 164 168 2-s2.0-47749155179 10.1016/j.bbrc.2008.07.007
160. Su D., Zhu S., Han X., Feng Y., Huang H., Ren G., Pan L., Zhang Y., Lu J., Huang B., BMP4-Smad signaling pathway mediates adriamycin-induced premature senescence in lung cancer cells. Journal of Biological Chemistry 2009 284 18 12153 12164 2-s2.0-66449087481 10.1074/jbc.M807930200
161. Ketolainen J. M., Alarmo E. L., Tuominen V. J., Kallioniemi A., Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4. Breast Cancer Research and Treatment 2010 124 2 377 386 2-s2.0-78649334675 10.1007/s10549-010-0808-0
162. Hogan B. L. M., Bone morphogenetic proteins in development. Current Opinion in Genetics and Development 1996 6 4 432 438 2-s2.0-0030218004 10.1016/S0959-437X(96)80064-5 (Pubitemid 26280795)
163. Balemans W., van Hul W., Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Developmental Biology 2002 250 2 231 250 2-s2.0-0036399170 10.1016/S0012-1606(02)90779-7 (Pubitemid 35216412)
164. Chen D., Zhao M., Mundy G. R., Bone morphogenetic proteins. Growth Factors 2004 22 4 233 241 2-s2.0-12344291865 10.1080/08977190412331279890 (Pubitemid 40136452)
165. Villaret A. B., Schreiber A., Facchetti F., Fisogni S., Lonardi S., Lombardi D., Cocco D., De Zinis L. O. R., Nicolai P., Immunostaining patterns of CD31 and podoplanin in previously untreated advanced oral/oropharyngeal cancer: prognostic implications. Head and Neck 2010 32 6 786 792 2-s2.0-77952762286 10.1002/hed.21256
166. Vormittag L., Thurnher D., Geleff S., Pammer J., Heiduschka G., Brunner M., Grasl M. C., Erovic B. M., Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy. International Journal of Radiation Oncology Biology Physics 2009 73 3 913 918 2-s2.0-59649121301 10.1016/j.ijrobp.2008.10. 040
167. Margaritescu C., Raica M., Pirici D., Simionescu C., Mogoanta L., Stinga A. C., Stinga A. S., Ribatti D., Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study. Histology and Histopathology 2010 25 6 701 711 2-s2.0-77953387362
168. Kreppel M., Drebber U., Wedemeyer I., Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy. Oral Oncology 2011 47 9 873 878 10.1016/j.oraloncology.2011. 06.508
169. Kawaguchi H., El-Naggar A. K., Papadimitrakopoulou V., Ren H., Fan Y. H., Feng L., Lee J. J., Kim E., Waun K. H., Lippman S. M., Mao L., Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. Journal of Clinical Oncology 2008 26 3 354 360 2-s2.0-38649137242 10.1200/JCO.2007.13. 4072 (Pubitemid 351171684)
170. Shi P., Liu W., Zhou Z. T., He Q. B., Jiang W. W., Podoplanin and ABCG2: malignant transformation risk markers for oral lichen planus. Cancer Epidemiology Biomarkers and Prevention 2010 19 3 844 849 2-s2.0-77949698444 10.1158/1055-9965.EPI-09-0699
171. Abbey L. M., Kaugars G. E., Gunsolley J. C., Burns J. C., Page D. G., Svirsky J. A., Eisenberg E., Krutchkoff D. J., Cushing M., Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and 1995 80 2 188 191 2-s2.0-0029351958
172. De Sousa S. F., Gleber-Netto F. O., De Oliveira-Neto H. H., Batista A. C., Nogueira Guimarães Abreu M. H., De Aguiar M. C. F., Lymphangiogenesis and podoplanin expression in oral squamous cell carcinoma and the associated lymph nodes. Applied Immunohistochemistry and Molecular Morphology 2012 20 6 588 594 10.1097/PAI.0b013e31824bb3ea
173. Friedrich R. E., Bartel-Friedrich S., Hagel C., Expression of podoplanin in primary and metastatic poorly differentiated and undifferentiated carcinomas of the head and neck. Anticancer Research 2012 32 5 2019 2022
174. Inoue H., Miyazaki Y., Kikuchi K., Ide F., Ohmori Y., Sakashita H., Kusama K., Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity. Tumor Biology 2012 33 1 183 194 10.1007/s13277-011-0261-7
175. Kreppel M., Wedemeyer I., Mauch C., Zöller J. E., Scheer M., Podoplanin expression in cutaneous head and neck squamous cell carcinoma-prognostic value and clinicopathologic implications. Journal of Surgical Oncology 2012 10.1002/jso.23238
176. Shimamura Y., Abe T., Nakahira M., Yoda T., Murata S.-I., Immunohistochemical analysis of oral dysplasia: diagnostic assessment by fascin and podoplanin expression. Acta Histochemica et Cytochemica 2011 44 6 239 245 10.1267/ahc.11032
177. Feng J.-Q., Mi J.-G., Wu L., Ma L.-W., Yang X., Liu W., Zhang C.-P., Zhou Z.-T., Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development. Oral Oncology 2012 48 9 848 852 10.1016/j.oraloncology. 2012.03.015
178. Hjelmeland A. B., Rich J. N., The quest for self-identity: not all cancer stem cells are the same. Clinical Cancer Research 2012 18 13 3495 3498 10.1158/1078-0432.CCR-12-1456
179. Krishnamurthy S., Dong Z., Vodopyanov D., Imai A., Helman J. I., Prince M. E., Wicha M. S., Nör J. E., Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells. Cancer Research 2010 70 23 9969 9978 2-s2.0-78649939527 10.1158/0008-5472.CAN-10-1712
180. Moharamzadeh K., Brook I. M., van Noort R., Scutt A. M., Thornhill M. H., Tissue-engineered oral mucosa: a review of the scientific literature. Journal of Dental Research 2007 86 2 115 124 2-s2.0-33847033428 10.1177/ 154405910708600203
181. Geissler C., Hambek M., Leinung M., Diensthuber M., Gassner D., Stöver T., Wagenblast J., The challenge of tumor heterogeneity-different phenotypes of cancer stem cells in a head and neck squamous cell carcinoma xenograft mouse model. In Vivo 2012 26 4 593 598
182. Wang T., Ong C. W., Shi J., Srivastava S., Yan B., Cheng C. L., Yong W. P., Chan S. L., Yeoh K. G., Iacopetta B., Salto-Tellez M., Sequential expression of putative stem cell markers in gastric carcinogenesis. British Journal of Cancer 2011 105 5 658 665 10.1038/bjc.2011.287
183. + T cells in melanoma patients. International Journal of Cancer 2009 124 10 2341 2346 2-s2.0-64249143619 10.1002/ijc.24235
184. Bumol T. F., Reisfeld R. A., Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proceedings of the National Academy of Sciences of the United States of America 1982 79 4 I 1245 1249 2-s2.0-0009691949 (Pubitemid 12105584)
185. Stallcup W. B., The NG2 antigen, a putative lineage marker: immunofluorescent localization in primary cultures of rat brain. Developmental Biology 1981 83 1 154 165 2-s2.0-0019880812
186. Pluschke G., vanek M., Evans A., Dittmar T., Schmid P., Itin P., Filardo E. J., Reisfeld R. A., Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proceedings of the National Academy of Sciences of the United States of America 1996 93 18 9710 9715 2-s2.0-0029796252 10.1073/pnas.93.18.9710 (Pubitemid 26296674)
187. Burg M. A., Grako K. A., Stallcup W. B., Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells. Journal of Cellular Physiology 1998 177 2 299 312 10.1002/(SICI)1097- 4652(199811)177:2<299::AID-JCP12>3.0.CO;2-5 (Pubitemid 28452831)
188. Yang J., Price M. A., Gui Y. L., Bar-Eli M., Salgia R., Jagedeeswaran R., Carlson J. H., Ferrone S., Turley E. A., McCarthy J. B., Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition. Cancer Research 2009 69 19 7538 7547 2-s2.0-70350227318 10.1158/0008-5472.CAN-08-4626
189. Iida J., Wilhelmson K. L., Ng J., Lee P., Morrison C., Tam E., Overall C. M., McCarthy J. B., Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A). Biochemical Journal 2007 403 3 553 563 2-s2.0-34247868828 10.1042/BJ20061176 (Pubitemid 46706984)
190. Müller A., Homey B., Soto H., Ge N., Catron D., Buchanan M. E., McClanahan T., Murphy E., Yuan W., Wagner S. N., Barrera J. L., Mohar A., Verástegui E., Zlotnik A., Involvement of chemokine receptors in breast cancer metastasis. Nature 2001 410 6824 50 56 2-s2.0-0035282432 10.1038/35065016 (Pubitemid 32225831)
191. Taichman R. S., Cooper C., Keller E. T., Pienta K. J., Taichman N. S., McCauley L. K., Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Research 2002 62 6 1832 1837 2-s2.0-0037085938 (Pubitemid 34408510)
192. Oonuma T., Morimatsu M., Nakagawa T., Uyama R., Sasaki N., Nakaichi M., Tamamura H., Fujii N., Hashimoto S., Yamamura H., Syuto B., Role of CXCR4 and SDF-1 in mammary tumor metastasis in the cat. Journal of Veterinary Medical Science 2003 65 10 1069 1073 2-s2.0-0642304318 10.1292/jvms.65.1069 (Pubitemid 41380061)
193. Tamamura H., Hori A., Kanzaki N., Hiramatsu K., Mizumoto M., Nakashima H., Yamamoto N., Otaka A., Fujii N., T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer. FEBS Letters 2003 550 1-3 79 83 2-s2.0-0142102523 10.1016/S0014-5793(03)00824-X (Pubitemid 37281361)
194. Libura J., Drukala J., Majka M., Tomescu O., Navenot J. M., Kucia M., Marquez L., Peiper S. C., Barr F. G., Janowska-Wieczorek A., Ratajczak M. Z., CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 2002 100 7 2597 2606 2-s2.0-0036786348 10.1182/blood-2002-01-0031
195. Kato M., Kitayama J., Kazama S., Nagawa H., Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Research 2003 5 5 R144 R150 2-s2.0-0141685979
196. Kucia M., Reca R., Miekus K., Wanzeck J., Wojakowski W., Janowska-Wieczorek A., Ratajczak J., Ratajczak M. Z., Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005 23 7 879 894 2-s2.0-23844513413 10.1634/stemcells.2004-0342 (Pubitemid 41170944)
197. Yun C. C., Sun H., Wang D., Rusovici R., Castleberry A., Hall R. A., Shim H., LPA2 receptor mediates mitogenic signals in human colon cancer cells. American Journal of Physiology 2005 289 1 C2 C11 2-s2.0-22244473681 10.1152/ajpcell.00610.2004 (Pubitemid 40880819)
198. Swart G. W. M., Activated leukocyte cell adhesion molecule (CD166/ALCAM): developmental and mechanistic aspects of cell clustering and cell migration. European Journal of Cell Biology 2002 81 6 313 321 2-s2.0-0035985278 (Pubitemid 34692942)
199. +-myo-inositol transporter SLC2A13 as a potential marker for cancer stem cells in an oral squamous cell carcinoma. Current Cancer Drug Targets 2011 11 8 966 975 10.2174/ 156800911797264752
200. Martín-Villar E., Scholl F. G., Gamallo C., Yurrita M. M., Muñoz-Guerra M., Cruces J., Quintanilla M., Characterization of human PA2.26 antigen (T1 α -2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas. International Journal of Cancer 2005 113 6 899 910 2-s2.0-11844289678 10.1002/ijc.20656 (Pubitemid 40096869)
201. Yuan P., Temam S., El-Naggar A., Zhou X., Liu D. D., Lee J. J., Mao L., Overexpression of podoplanin in oral cancer and its association with poor clinical outcome. Cancer 2006 107 3 563 569 2-s2.0-33746284520 10.1002/cncr.22061 (Pubitemid 44107217)
202. Kreppel M., Scheer M., Drebber U., Ritter L., Zöller J. E., Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations. Virchows Archiv 2010 456 5 473 482 2-s2.0-77952502329 10.1007/s00428-010-0915-7
203. Rodrigo J. P., García-Carracedo D., González M. V., Mancebo G., Fresno M. F., García-Pedrero J., Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas. Molecular Cancer 2010 9, article 48 2-s2.0-77950547974 10.1186/1476-4598-9-48
204. Huber G. F., Fritzsche F. R., Züllig L., Storz M., Graf N., Haerle S. K., Jochum W., Stoeckli S. J., Moch H., Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. International Journal of Cancer 2011 129 6 1404 1409 2-s2.0-79960915225 10.1002/ijc.25795
205. Funayama A., Cheng J., Maruyama S., Yamazaki M., Kobayashi T., Syafriadi M., Kundu S., Shingaki S., Saito C., Saku T., Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas. Pathobiology 2011 78 3 171 180 10.1159/000324926
206. El-Sayed I. H., Nanotechnology in head and neck cancer: the race is on. Current Oncology Reports 2010 12 2 121 128 2-s2.0-77952242785 10.1007/s11912-010-0087-2